Description: Presented at October 1986 Annual Meeting. This session discussion is about the impact of the AIDS epidemic, legal challenges to risk classification practices, impact on practices resulting from these challenges and from trends in areas such as preferred risks and guaranteed issues, possible future developments in underwriting and risk classification and how they may impact product design and marketing.

Description: Session 176: The Future of Medical Records in Underwriting

Description: Presented at May 2005 Spring Meeting. Panelists discuss the insuring of the aging population in respect to assessment of the health of the insured and resulting mortality costs.

Description: This session reviewed the distinctions and blurring of those distinctions between group and individual life insurance. Topics include differences in underwriting, legal constraints, marketing and distribution, and the nature of guarantees provided

Description: This discussion at the SOA 1997 Palm Desert Spring Meeting looks at issues related to second-hand smoke including the negative health effects and underwriting implications.

Description: Breakout Sessions 1A: The Fundamentals of Pricing for Underwriters

Description: Big data and predictive models have disrupted the life insurance new business and underwriting processes over the past few years. How did we get here? What does the future hold? This session will review the lessons learned from the evolutionary process and discuss what the potential next steps are in this journey. Are real time fully underwritten decisions an achievable goal?

Description: This is the digest from the informal discussion reviewing the 1951 Impairment study. It is the latest in a series of studies covering mortality of impaired risks. It covers the experience under Ordinary insurance issued from 1935 to 1949 traced to the anniversaries in 1950. Standard and substandard policies were studied separately.

Description: This session at the SOA 1990 Annual Meeting explores the status and impact of AIDS in the U.S., Canada and elsewhere in the world.

Description: Discusses: [1] using blood tests effectively to improve mortality results, [2] using expert underwriting systems, and [3] what the future may hold for genetic underwriting. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.